MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma	https://doi.org/10.1159/000430172	2015	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-128 inhibits EMT of human osteosarcoma cells by directly targeting integrin ?2	https://doi.org/10.1007/s13277-015-4696-0	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response	https://doi.org/10.1002/ijc.25715	2011	Cell line 10 Master/Detail View	Cell line and drug 3 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
In vitro and in vivo studies of antiosteosarcoma activities of formononetin	https://doi.org/10.1002/jcp.28349	2019	Cell line 0 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells	https://doi.org/10.1002/stem.1618	2014	Cell line 2 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples	https://doi.org/10.1016/j.bbrc.2009.07.101	2009	Cell line 6 Master/Detail View	Cell line and drug 3 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1?	https://doi.org/10.1042/BSR20170080	2019	Cell line 3 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
The anti-osteosarcoma property of ailanthone through regulation of miR-126/VEGF-A axis	https://doi.org/10.1080/21691401.2019.1669622	2019	Cell line 2 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-23a functions as a tumor suppressor in osteosarcoma	https://doi.org/10.1159/000366353	2014	Cell line 2 Master/Detail View	Cell line and drug 5 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Triptolide inhibits the growth of osteosarcoma by regulating microRNA-181a via targeting PTEN gene in vivo and vitro	https://doi.org/10.1177/1010428317697556	2017	Cell line 0 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Tumor Suppressor Function of miR-127-3p and miR-376a-3p in Osteosarcoma Cells	https://doi.org/10.3390/cancers11122019	2019	Cell line 12 Master/Detail View	Cell line and drug 6 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
DNA Methylation Mediated Downregulation of miR-449c Controls Osteosarcoma Cell Cycle Progression by Directly Targeting Oncogene c-Myc	https://doi.org/10.7150/ijbs.19476	2017	Cell line 2 Master/Detail View	Cell line and drug 4 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-329 suppresses osteosarcoma development by downregulating Rab10	https://doi.org/10.1002/1873-3468.12337	2016	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma	https://doi.org/10.1002/cam4.2320	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
NAIF1 suppresses osteosarcoma progression and is regulated by miR-128	https://doi.org/10.1002/cbf.3365	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Interplay Between Long Noncoding RNA ZEB1-AS1 and miR-200s Regulates Osteosarcoma Cell Proliferation and Migration	https://doi.org/10.1002/jcb.25879	2017	Cell line 10 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-126 Inhibits Proliferation, Migration, Invasion, and EMT in Osteosarcoma by Targeting ZEB1	https://doi.org/10.1002/jcb.26024	2017	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Inhibition of microRNA-940 suppresses the migration and invasion of human osteosarcoma cells through the secreted frizzled-related protein 1-mediated Wnt/?-catenin signaling pathway	https://doi.org/10.1002/jcb.27580	2018	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-421 promotes apoptosis and suppresses metastasis of osteosarcoma cells via targeting LTBP2	https://doi.org/10.1002/jcb.28144	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Dysregulated circRNA_100876 suppresses proliferation of osteosarcoma cancer cells by targeting microRNA-136	https://doi.org/10.1002/jcb.28837	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View

Publications